Int. J. Environ. Res. Public Health 2010, 7(5), 2045-2056; doi:10.3390/ijerph7052045

Article
Estrogenic Activity of Coumestrol, DDT, and TCDD in Human Cervical Cancer Cells
Kenneth Ndebele 1,, Barbara Graham 1, and Paul B. Tchounwou 2,*
1
The Laboratory of Cancer Immunology, Target Identification and Validation, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA; E-Mails: kenneth.ndebele@jsums.edu (K.N.); Barbara.e.graham@jsums.edu (B.G.)
2
Molecular Toxicology Research Laboratory, NIH- Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA
These authors contributed equally.
*
Author to whom correspondence should be addressed; E-Mail: paul.b.tchounwou@jsums.edu; Tel.:+1-601-979-0777; Fax: +1-601-979-0570
Received: 20 January 2010; in revised form: 30 March 2010 / Accepted: 3 April 2010 /
Published: 4 May 2010

Abstract

: Endogenous estrogens have dramatic and differential effects on classical endocrine organ and proliferation. Xenoestrogens are environmental estrogens that have endocrine impact, acting as both estrogen agonists and antagonists, but whose effects are not well characterized. In this investigation we sought to delineate effects of xenoestrogens. Using human cervical cancer cells (HeLa cells) as a model, the effects of representative xenoestrogens (Coumestrol-a phytoestrogen, tetrachlorodioxin (TCDD)-a herbicide and DDT-a pesticide) on proliferation, cell cycle, and apoptosis were examined. These xenoestrogens and estrogen inhibited the proliferation of Hela cells in a dose dependent manner from 20 to 120 nM suggesting, that 17-β-estrtadiol and xenoestrogens induced cytotoxic effects. Coumestrol produced accumulation of HeLa cells in G2/M phase, and subsequently induced apoptosis. Similar effects were observed in estrogen treated cells. These changes were associated with suppressed bcl-2 protein and augmented Cyclins A and D proteins. DDT and TCDD exposure did not induce apoptosis. These preliminary data taken together, suggest that xenoestrogens have direct, compound-specific effects on HeLa cells. This study further enhances our understanding of environmental modulation of cervical cancer.
Keywords:
xenoestrogens; Coumestrol; DDT; TCDD; Cell Cycle

1. Introduction

Endogenous estrogens, especially 17-β-estradiol, have significant impact on cell mediated and humoral immune and autoimmune responses [15]. Derived from plant or industrial synthesis, environmental xenobiotics with potential estrogenic or hormonal activities are known as xenoestrogens. These compounds are ubiquitous, exhibit bioaccumulation, and act as estrogen agonists or antagonists, disrupting normal endocrine axes [615]. Xenoestrogens have significantly weaker binding affinities than endogenous estrogens to traditional steroid receptors [9,14,15] and their medical, environmental, and societal impact is the frequent subject of debate [12,13]. Representative xenoestrogens include compounds such as coumestrol, a phytoestrogen found in high levels in legumes that acts as an estrogen agonist. Coumestrol has been shown to modulate production of thymic hormones [17]. DDT (o,p-dichlorodiphenyltrichloroethane), a synthetic organochlorine pesticide, has a weak estrogenic agonist activity (as well as androgen antagonist activity) [21] and has been associated with immunosuppression in murine models [2224] and modulation of cell cycle and apoptosis [2527], but its effects on other diseases such as cervical cancer has not been characterized. TCDD (tetrachlorodibenzo-p-dioxin), a polychlorinated biphenyl dioxin, has been widely studied with variable results, having both estrogen agonist and antagonist activity [6,14,21]. It has also been found to modulate cell cycle proteins [29], induce thymic involution [30], and modulate cytokine expression [31,32]. Xenoestrogens may act at the cellular and molecular levels, binding to both steroid and aryl hydrocarbon receptors exhibiting both dependent and independent receptor modulations of specific gene transcriptional elements [29,3235]. As a result, xenoestrogens have the potential to variably modulate cell proliferation, cell cycle progression, apoptosis and cytokine production in much the same way as 17-β-estradiol does [3640]. This modulation is likely to occur in association with alterations in bcl-2 or p53 protein levels [29,38,39]. In this investigation, using the HeLa cell line as a model we explored xenoestrogen-specific effects.

2. Material and Methods

Reagents and Cell Culture

Human cervical cancer (HeLa) cells were purchased from American Type Culture Collection (Rockville, MD), maintained in logarithmic growth, and cultured in DMEM. Cells were cultured in a density between 0.1 and 1.0 × 106/mL. Medium was deemed complete when supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin. The cells were cultured in suspension at 37°C and 5% CO2 in a humidified incubator and carried at 0.1–2.0 × 106 cells/mL, passaging two to three times weekly as needed. Cells were pelleted and resuspended in fresh complete medium in tissue culture plates 24 h before use in experiments to avoid any confounding gene expression that might occur because of handling. Xenoestrogens were dissolved in 1,4-dioxane or DMSO with final concentrations of solvent in control or treated cultures < 0.1%.

Proliferation Assay

Cells were cultured in triplicate at 1.0 × 106/mL for 72 h, treated with different concentrations (0, 20, 40, 60, 80, 90 nM) of 17-β-estradiol, coumestrol, DDT and TCDD. Proliferation was measured by determination of total viable cell mass using the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay Kit (Promega, Madison, WI) according to the manufacturer’s instructions. Absorbance at 490 nm was determined on a Bio-Rad (Hercules, CA) plate reader.

Cell Cycle Analysis

Cell cycle analysis was performed as previously described [38,39]. Briefly, 1 × 106 cells /mL were grown in suspension, harvested by centrifugation, washed, and fixed in 1% paraformaldehyde. After washing, the cells were permeabilized in 70% ethanol, washed, and re-suspended in PBS. RNase (Sigma) was added at a final concentration of 5 U/mL. Cells were stained with propidium iodide (PI). Flow microfluorometry was performed and DNA histograms were generated and analyzed using a Becton Dickinson Flowscan (Franklin Lakes, NJ). This method correlates closely with other measures of apoptosis including TUNEL and Annexin V staining while providing additional cell cycle information [41]. This method also allows for enumeration of the percentages of cells in G0/G1 (resting phase), S (DNA synthesis phase), G2M (mitotic phase), and hypodiploid or apoptotic percentages (those cells containing less than the normal amount of DNA) [41].

Western Blot Analysis

For Western analysis, 5 × 106 cells were cultured, treated with various concentrations of estrogen, coumestrol, DDT and TCDD compounds. Total protein concentration was determined by the method of Bradford using Bio-Rad Protein Assay reagents (Bio-Rad) in a microtiter assay plate. Total cellular protein (30ug) was electrophoresed on 12.5% SDS-PAGE gel, transferred to a polyvinylidine difluoride membrane (Amersham, Arlington Heights, IL) by electroblotting overnight. Membranes were blocked with 10% electrophoresis grade biotin-depleted non-fat dry milk (BioRad) in 1 X PBS (10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween-20), rinsed in PBS, probed with monoclonal mouse anti-human bcl-2, Cyclin A and D (BD Bioscience San Diego, CA) using 1:1,000 dilution, and washed 3 times in PBS. The secondary antibody was HRP-conjugated goat anti-mouse whole IgG used at 1:1,000 (Transduction Laboratories). All antibodies were diluted in 1% milk in TBS. Membranes were washed three times. Detection of membrane-bound proteins was carried out by enhanced chemiluminesence with an ECL reagent kit (using 0.06 mL/cm2 of reagent) and Hybond autoradiography film (both Amersham). Biotinylated standards were used for molecular weight determination and were detected with 1:3,000 streptavidin-horseradish peroxidase (Amersham).

3. Results

Xenoestrogen Effects on HeLa Cell Proliferation

Study results show compound-specific effects on accumulation of viable HeLa cell mass. 17-β-estradiol and TCDD were used as representative controls of endogenous and environmental anti-estrogen compounds. In Figure 1, coumestrol, DDT and TCDD exhibited concentration dependent (20 to 120 nM) suppression on HeLa cell proliferation, indicating the cytotoxic effects of 17-β-estradiol [3639]. Viable cell mass was assessed by MTT assay (see Methods). Change in total cell number was confirmed in cell cultures by enumeration (not shown). * p < 0.05 was determined using ANOVA with Bonferroni correction for multiple comparisons.

Estrogen Suppresses Bcl-2 in a Dose-Dependent Manner

Members of the bcl-2 family are crucial regulators of apoptosis in mammalian cells. The bcl-2 family includes antiapoptotic proteins, such as Bcl-2, and proapoptotic proteins, such as Bax. Since estrogen induced apoptosis is dependent on time and dose, we first tested bcl-2 response to estrogen. HeLa cells demonstrated a dose-dependent decrease (20, 40, 60, 80, 90 nM) in the expression of the antiapoptotic Bcl-2 protein upon estrogen treatment (Figure 2).

Xenoestrogen Modulation of Cell Cycle Phase Distribution

Cell accumulation or growth is a homeostatic balance between proliferation and apoptosis [42,43]. Questions have been raised regarding the MTT assay as a measure of viable cell mass, especially for xenoestrogens [44]. Therefore, xenoestrogen effects on cell cycle phase distribution in HeLa cells was also assessed by propidium iodide (PI) staining [38,39]. Representative cell cycle histograms for 17-β-estradiol, coumestrol, DDT and TCDD are shown in Figure 3, 17-β-estradiol and coumestrol had significant cell cycle phase effect on actively growing HeLa cells, causing redistribution from G0/G1 to apoptosis (p < 0.01), whereas TCDD and DDT had minimal effect, when analyzed by PI staining.

Xenoestrogen Suppression of Bcl-2 and Stimulation of Cyclin A and D

Bcl-2, Cyclin A and D cell regulatory proteins modulate cell cycle progression and apoptosis [42,43,46]. Given the observed effects of xenoestrogens on HeLa cell proliferation and cell cycle distribution, examination of bcl-2, Cyclin A and D protein levels was performed. As shown in representative Western blots (Figure 4; n = 3), xenoestrogens DDT, coumestrol, and 17-β-estradiol suppressed bcl-2 protein whereas, anti-estrogen, TCDD did not have a significant effect on bcl-2 expression as compared to the control. DDT, coumestrol and TCDD increased Cyclin A and D protein levels to variable degrees in HeLa cells (Figures 5 and 6 respectively). These preliminary results are consistent with recent reports of potential modulation of bcl-2 by xenoestrogens [4750], supporting the concept that xenoestrogens may modulate cancer cell biology through associated changes in bcl-2.

4. Discussion

In this study we examined xenoestrogen’s direct actions on proliferation, cell cycle phase distribution and apoptosis in Hela cells. While the HeLa cells used in this study are transformed and may not accurately reflect primary cervical cells in vivo, they serve as a useful model and a basis for further examination of direct effects of xenoestrogens. As others have reported [51,52], and we confirmed in this investigation, xenoestrogens have a marked overall suppression effect on HeLa cell proliferation.

Xenoestrogen concentration used in this study, while supraphysiological, were comparable to those known to maximally stimulate estrogen receptor transcriptional activity [53]. Based on previous in vitro studies, xenoestrogens in the range of 20 nM to 120 nM demonstrate maximal effects on cell apoptosis and cell differentiation [28,54] and these high concentrations may be required in transformed cell lines. Although the concentrations in this investigation are some what higher that those found in the environment, long-term bioacccumulative actions may be anticipated to affect cancer cell biology. With receptor binding affinities up to 10,000 fold weaker than endogenous estrogens, the environmental impact of xenoestrogens is the subject of scientific and societal debate [51,55]. These preliminary studies of representative xenoestrogens have been designed to detect and dissect potential effects on HeLa cells.

Xenoestrogens are environmental hormones or compounds that exhibit estrogenic activity. They may interact with or disrupt endogenous estrogenic activity, and, as suggested by some investigations, may have implications for health and disease [27,56]. In the present study, estrogen, coumestrol and DDT, but not TCDD were shown to variably but significantly suppress bcl-2 protein expression in HeLa cells. However, DDT, coumestrol and TCDD upregulated cyclin A and D protein expression. The variability is likely due to xenoestrogenic potency with respect to estrogenic activity [57,58], as well as possible differences in mechanisms of action [2325]. Nevertheless, our experimental data suggest that these specific xenoestrogens, at high concentrations, have specific effects on HeLa cells.

While concentrations of xenoestrogens used in this study may exceed those detected in the environment and the general population, chronic, low level of exposure is known to have biological effects [58,60]. The purpose of this investigation was to identify possible mechanisms of HeLa cell modulation and not necessarily establish environmental exposure-based cause-and-effect evidence. Furthermore, acute in vitro effects cannot be adequately extrapolated to chronic, low dose exposure in vivo effects. Hence, results in the current study should be interpreted with utmost caution. Observed effects occurred only in selected xenoestrogens, implying that effects may be compound-specific and that broad generalization for individual compounds are not appropriate. Data in the current study suggest a direct induction of apoptosis by estrogen and coumestrol, but not DDT AND TCDD. While verification and extension of our results is needed, the apoptosis induced in estrogen and coumestrol suggests at least one of potential effects, by which some xenoestrogens affect cell viability and induce cell death.

The effects observed in the current study may be estrogen receptor dependent or independent [61]. Jeon and Esser have shown that TCDD elicits its biological function through binding of the AHR to distal DNA motifs [62]. However, xenoestrogens may also have AHR receptor independent effects on hela cells and xenoestrogen mechanisms of action are likely pleiotropic [63]. Delineating xenoestrogen-mediated effects through the ER or AHR is pivotal to understanding molecular mechanisms of xenoestrogens, but is beyond the scope of this initial study.

This research was financially supported in part by NIH-RCMI grant # G12RR013459.

References

  1. Whitacre, CC; Reingold, SC; O’Looney, PA. Task force on gender, multiple sclerosis and autoimmunity. A gender gap in autoimmunity. Science 1999, 283, 1277–1278.
  2. Verthelyi, D. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol 2001, 1, 983–993.
  3. Olsen, NJ; Kovacs, WJ. Gonadal steroids and immunity. Endocrine. Rev 1996, 17, 369–384.
  4. Fox, HS. Sex steroids and the immune system. Ciba Foundation Symposium 1995, 191, 203–211.
  5. McMurray, RW. Estrogen, prolactin, and autoimmunity: actions and interactions. Int. Immunopharmacol 2001, 1, 995–1008.
  6. Wolff, MS. Environmental estrogens. Environ. Health Perspect 1995, 103, 784–785.
  7. Safe, SH. Endocrine disrupters and human health—is there a problem? An update. Environ. Health Perspect 2000, 108, 487–93.
  8. Kaiser, J. Endocrine disrupters. Panel cautiously confirms low-dose effects. Science 2000, 290, 695–697.
  9. Neubert, D. Vulnerability of the endocrine system to xenobiotic influence. Reg. Toxicol. Pharmacol 1997, 26, 9–29.
  10. Ahmed, SA; Hissong, BD; Verthelyi, D; Donner, K; Becker, K; Karpuzoglu-Sahin, E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect 1999, 5, 681–686.
  11. Ashby, J. Testing for endocrine disruption post-EDSTAC: extrapolation of low dose rodent effects to humans. Toxicol. Lett 2001, 120, 233–242.
  12. Crinnion, WJ. Environmental medicine, part one: the human burden of environmental toxins and their common health effects. Altern. Med. Rev 2000, 5, 52–63.
  13. Ziegler, J. Environmental “endocrine disrupters” get a global look. J. Natl. Cancer Inst 1997, 89, 1184–1187.
  14. Barton, HA; Andersen, ME. Endocrine active compounds: from biology to dose response assessment. Crit. Rev. Toxicol 1998, 28, 363–423.
  15. Barton, HA; Andersen, ME. Dose-response assessment strategies for endocrine-active compounds. Regul. Toxicol. Pharmacol 1997, 25, 292–305.
  16. Domon, OE; McGarrity, LJ; Bishop, M; Yoshioka, M; Chen, JJ; Morris, SM. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK(+/−) human lymphoblastoid cells. Mutat. Res 2001, 474, 129–137.
  17. Sakabe, K; Okuma, M; Karaki, S; Matsuura, S; Yoshida, T; Aikawa, H; Izumi, S; Kayama, F. Inhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture. Int. J. Immunopharmacol 1999, 21, 861–868.
  18. Hiroi, H; Tsutsumi, O; Momoeda, M; Takai, Y; Osuga, Y; Taketani, Y. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta. Endocr. J 1999, 46, 773–778.
  19. Howdeshell, KL; Hotchkiss, AK; Thayer, KA; Vandenbergh, JG; vom Saal, FS. Exposure to bisphenol A advances puberty. Nature 1999, 401, 763–764.
  20. Sakazaki, H; Ueno, H; Nakamuro, K. Estrogen receptor alpha in mouse splenic lymphocytes:possible involvement in immunity. Toxicol. Lett 2002, 133, 221–229.
  21. Tapiero, H; Ba, GN; Tew, KD. Estrogens and environmental estrogens. Biomed. Pharmacother 2002, 56, 36–44.
  22. Street, JC; Sharma, RP. Alteration of induced cellular and humoral immune responses by pesticides and chemicals of environmental concern: quantitative studies of immunosuppression by DDT, aroclor 1254, carbaryl, carbofuran, and methylparathion. Toxicol. Appl. Pharmacol 1975, 32, 587–602.
  23. Banerjee, BD; Koner, BC; Ray, A. Influence of stress on DDT-induced humoral immune responsiveness in mice. Environ. Res 1997, 74, 43–47.
  24. Koner, BC; Banerjee, BD; Ray, A. Organochlorine pesticide-induced oxidative stress and immune suppression in rats. Indian J. Exp. Biol 1998, 36, 395–398.
  25. Dees, C; Askari, M; Foster, JS; Ahamed, S; Wimalasena, J. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Mol. Carcinog 1997, 18, 107–114.
  26. Diel, P; Olff, S; Schmidt, S; Michna, H. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J. Steroid. Biochem. Mol. Biol 2002, 80, 61–70.
  27. Ziegler, J. Environmental “endocrine disrupters” get a global look. J. Natl. Cancer Inst 1997, 89, 1184–1187.
  28. Ndebele, K; Tchounwou, PB; McMurray, RW. Effects of xenoestrogens on T lymphocytes: Modulation of Bcl2, p53, and apoptosis. Int. J. Mol. Sci 2003, 4, 45–61.
  29. Silverstone, AE; Frazier, DE, Jr; Fiore, NC; Soults, JA; Gasiewicz, TA. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol 1994, 126, 248–259.
  30. Kamath, AB; Xu, H; Nagarkatti, PS; Nagarkatti, M. Evidence for the induction of apoptosis in thymocytes by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol 1997, 142, 367–377.
  31. Prell, RA; Oughton, JA; Kerkvliet, NI. Effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int. J. Immunopharmacol 1995, 17, 951–961.
  32. Lai, ZW; Hundeiker, C; Gleichmann, E; Esser, C. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-pdioxin. Mol. Pharmacol 1997, 52, 30–37.
  33. Jeon, MS; Esser, C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol 2000, 165, 6975–6983.
  34. Kharat, I; Saatcioglu, F. Antiestrogenic effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem 1996, 271, 10533–10537.
  35. Hossain, A; Tsuchiya, S; Minegishi, M; Osada, M; Ikawa, S; Tezuka, FA; Kaji, M; Konno, T; Watanabe, M; Kikuchi, H. The Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo- pdioxin-mediated apoptosis in human leukemic T cell lines. J. Biol. Chem 1998, 273, 19853–19858.
  36. Blagosklonny, MV; Neckers, LM. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Letters 1994, 76, 81.
  37. Kincade, PW; Medina, KL; Smithson, G. Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev 1994, 137, 119–134.
  38. Jenkins, JK; Suwannaroj, S; Elbourne, KB; Ndebele, K; McMurray, RW. 17-β-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of bcl-2 and cyclin A. Internat. J. Immunopharmacol 2001, 11, 1897–1911.
  39. McMurray, RW; Suwannaroj, S; Ndebele, K; Jenkins, JK. Differential effects of sex steroids on T and B lymphocytes: modulation of cell cycling, apoptosis, and bcl-2. Pathobiol 2001, 69, 44–58.
  40. McMurray, RW; Ndebele, K; Jenkins, JK. 17-β-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001, 14, 324–333.
  41. Nicoletti, I; Migliorati, G; Pagliacci, MC; Grignani, F; Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139, 271.
  42. Cohen, JJ. Programmed cell death in the immune system. Adv. Immunol 1991, 50, 55.
  43. King, KL; Cidlowski, JA. Cell cycle and apoptosis: common pathways to life and death. J. Cell Biochem 1995, 58, 175.
  44. Pagliacci, MC; Spinozzi, F; Migliorati, G; Fumi, G; Smacchia, M; Grignani, F; Riccardi, C; Nicoletti, I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer 1993, 29A, 1573–1577.
  45. Neumann, CM; Oughton, JA; Kerkvliet, NI. Anti-CD3-induced T-cell activation—II. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Intenat. J. Immunopharmacol 1993, 15, 543–550.
  46. Huang, DC; O’Reilly, LA; Strasser, A; Cory, S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO Journal 1997, 16, 4628–4635.
  47. Kannan, K; Holcombe, RF; Jain, SK; Alvarez-Hernandez, X; Chervenak, R; Wolf, RE; Glass, J. Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Mol. Cell. Biochem 2000, 205, 53–66.
  48. Roy, D; Palangat, M; Chen, CW; Thomas, RD; Colerangle, J; Atkinson, A; Yan, ZJ. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health 1997, 50, 1–29.
  49. Rininger, JA; Stoffregen, DA; Babish, JG. Murine hepatic p53, RB, and CDK inhibitory protein expression following acute 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Chemosphere 1997, 34, 1557–1568.
  50. Burrow, ME; Tang, Y; Collins-Burow, BM; Krajewski, S; Reed, JC; McLachlan, JA; Beckman, BS. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis 1999, 20, 2057–2061.
  51. Schimpl, A; Berberich, I; Kneitz, B; Kramer, S; Santner-Nanan, B; Wagner, S; Wolf, M; Hunig, T. IL-2 and autoimmune disease. Cytokine Growth Factor Rev 2002, 13, 369–378.
  52. Nohara, K; Fujimaki, H; Tsukumo, S; Inouye, K; Sone, H; Tohyama, C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice. Toxicology 2002, 172, 49–58.
  53. Karin, M; Delhase, M. The I kappa B kinase and NF-kB: key elements of proinflammatory signalling. Semin. Immunol 2000, 12, 85–98.
  54. Landegren, U; Andersson, J; Wigzell, H. Analysis of human T lymphocyte activation in a T cell tumor model system. Eur. J. Immunol 1985, 15, 308–311.
  55. Ray, A; Ray, P. Down modulation of interleukin 6 gene expression by 17B estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem 1994, 269, 12940–12946.
  56. Wolff, MS. Environmental estrogens. Environ. Health Perspect 1995, 103, 784–785.
  57. Safe, SH. Endocrine disrupters and human health—is there a problem? An update. Environ. Health Perspect 2000, 108, 487–493.
  58. Kaiser, J. Endocrine disrupters. Panel cautiously confirms low-dose effects. Science 2000, 290, 695–697.
  59. Sohoni, P; Sumpter, JP. Several environmental oestrogens are also anti-androgens. J. Endocrinol 1998, 158, 327–339.
  60. Ulrich, EM; Caperell-Grant, A; Jung, SH; Hites, RA; Bigsby, RM. Environmentally relevant xenoestrogen tissue concentrations correlated to biological responses in mice. Environ. Health Perspect 2000, 108, 973–977.
  61. Frigo, DE; Burow, ME; Mitchell, K; Chiang, TC; McLachlan, JA. DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environ. Health Perspect 2002, 110, 1239–1245.
  62. Jeon, MS; Esser, C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol 2000, 165, 6975–6983.
  63. Kharat, I; Saatcioglu, F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem 1996, 271, 10533–10537.
Ijerph 07 02045f1
Figure 1. HeLa cell viability over 72 h exposure to 20 to 120nM 17-β-estradiol (E), DDT (D), Coumestrol, TCDD vs. control/solvents (C). 17-β-estradiol, DDT, Coumestrol and TCDD had profound effects on HeLa cell proliferation.

Click here to enlarge figure

Figure 1. HeLa cell viability over 72 h exposure to 20 to 120nM 17-β-estradiol (E), DDT (D), Coumestrol, TCDD vs. control/solvents (C). 17-β-estradiol, DDT, Coumestrol and TCDD had profound effects on HeLa cell proliferation.
Ijerph 07 02045f1
Ijerph 07 02045f2
Figure 2. Expression of bcl-2 in HeLa cells exposed to17-β-estradiol (20, 40, 60, 80, and 90 nM) for 24 h. Western blot analysis of bcl-2 expression was performed as indicated in the Materials and Methods. Beta actin expression was used to assess equal lane loading.

Click here to enlarge figure

Figure 2. Expression of bcl-2 in HeLa cells exposed to17-β-estradiol (20, 40, 60, 80, and 90 nM) for 24 h. Western blot analysis of bcl-2 expression was performed as indicated in the Materials and Methods. Beta actin expression was used to assess equal lane loading.
Ijerph 07 02045f2
Ijerph 07 02045f3
Figure 3. Histograms showing representative cell cycle phases of β-estradiol, coumestrol, DDT and TCDD treated HeLa cells for 24 H. Flow microfluorometry was performed as indicated in the Materials and Methods. Percent of apoptotic cells (labeled M4) is β-estradiol ∼17%, DDT ∼5%, Coumestrol shown for comparison. Control ∼0.2%, 17 ∼ 30% and TCDD ∼3%.

Click here to enlarge figure

Figure 3. Histograms showing representative cell cycle phases of β-estradiol, coumestrol, DDT and TCDD treated HeLa cells for 24 H. Flow microfluorometry was performed as indicated in the Materials and Methods. Percent of apoptotic cells (labeled M4) is β-estradiol ∼17%, DDT ∼5%, Coumestrol shown for comparison. Control ∼0.2%, 17 ∼ 30% and TCDD ∼3%.
Ijerph 07 02045f3
Ijerph 07 02045f4
Figure 4. Expression of bcl-2 protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of bcl-2 expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.

Click here to enlarge figure

Figure 4. Expression of bcl-2 protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of bcl-2 expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.
Ijerph 07 02045f4
Ijerph 07 02045f5
Figure 5. Expression of cyclin A protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of cyclin A expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.

Click here to enlarge figure

Figure 5. Expression of cyclin A protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of cyclin A expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.
Ijerph 07 02045f5
Ijerph 07 02045f6
Figure 6. Expression of cyclin D protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of cyclin D expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.

Click here to enlarge figure

Figure 6. Expression of cyclin D protein in β-estradiol, DDT, coumestrol, and TCDD treated HeLa cells for 24 h. Western blot analysis of cyclin D expression was performed as indicated in the Materials and Methods. β actin expression was used to assess equal lane loading.
Ijerph 07 02045f6
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert